A potential primary endpoint for clinical trials in glaucoma neuroprotection
Crossref DOI link: https://doi.org/10.1038/s41598-023-34009-x
Published Online: 2023-05-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
De Moraes, Carlos Gustavo
Lane, Keith J.
Wang, Xiao
Liebmann, Jeffrey M.
Text and Data Mining valid from 2023-05-02
Version of Record valid from 2023-05-02
Article History
Received: 23 October 2022
Accepted: 22 April 2023
First Online: 2 May 2023
Competing interests
: The authors declare no competing interests.